|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Investment properties: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and other improvements | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Net investment properties | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and escrows | ||||||||||||||||||||
| Accounts and rents receivable, net of allowance for doubtful accounts | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization (Note 5) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax assets, net (Note 8) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets held for sale (Note 4) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Debt, net of loan premiums, discounts and unamortized deferred financing costs (Note 5) | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities associated with assets held for sale (Note 4) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock, $0.01 par value, 500,000,000 shares authorized, 92,245,835 and 92,153,929 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated distributions in excess of net earnings | ||||||||||||||||||||
| Total Company stockholders' equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
